Trial Profile
Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 06 Mar 2020
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Endometriosis
- Focus Therapeutic Use
- Acronyms END-IMPACT
- 08 Nov 2019 Status changed from not yet recruiting to discontinued.
- 17 Jan 2017 Planned End Date changed from 1 Feb 2019 to 1 Feb 2020.
- 17 Jan 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Jan 2020.